ATE338115T1 - Gdnf rezeptor - Google Patents
Gdnf rezeptorInfo
- Publication number
- ATE338115T1 ATE338115T1 AT97921203T AT97921203T ATE338115T1 AT E338115 T1 ATE338115 T1 AT E338115T1 AT 97921203 T AT97921203 T AT 97921203T AT 97921203 T AT97921203 T AT 97921203T AT E338115 T1 ATE338115 T1 AT E338115T1
- Authority
- AT
- Austria
- Prior art keywords
- gdnf
- receptor
- gdnfr
- found
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1590796P | 1996-04-22 | 1996-04-22 | |
| US1722196P | 1996-05-09 | 1996-05-09 | |
| US08/837,199 US6455277B1 (en) | 1996-04-22 | 1997-04-14 | Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE338115T1 true ATE338115T1 (de) | 2006-09-15 |
Family
ID=27360445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97921203T ATE338115T1 (de) | 1996-04-22 | 1997-04-15 | Gdnf rezeptor |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US6455277B1 (de) |
| EP (1) | EP0909316B1 (de) |
| JP (1) | JP2000509271A (de) |
| KR (1) | KR20000010571A (de) |
| CN (1) | CN1219967A (de) |
| AT (1) | ATE338115T1 (de) |
| AU (1) | AU720092B2 (de) |
| BR (1) | BR9708959A (de) |
| CA (1) | CA2250704C (de) |
| CZ (1) | CZ324598A3 (de) |
| DE (1) | DE69736597T2 (de) |
| EA (1) | EA002924B1 (de) |
| ES (1) | ES2271968T3 (de) |
| HU (1) | HUP9902640A3 (de) |
| IL (1) | IL126553A0 (de) |
| NO (1) | NO984757L (de) |
| NZ (1) | NZ332256A (de) |
| SK (1) | SK140398A3 (de) |
| WO (1) | WO1997040152A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696259B1 (en) * | 1995-11-13 | 2004-02-24 | Licentia Ltd. | Assays using glial cell line-derived neurotrophic factor receptors |
| US6677135B1 (en) | 1996-05-08 | 2004-01-13 | Biogen, Inc. | Ret ligand (RetL) for stimulating neutral and renal growth |
| CN1163509C (zh) * | 1996-05-08 | 2004-08-25 | 拜奥根有限公司 | 刺激神经和肾生长的RET配体(RetL) |
| US20020068361A1 (en) * | 1997-04-08 | 2002-06-06 | Douglas Clary | Methods of evaluating specific cellular functions of receptor protein tyrosine kinases in a ligand independent manner |
| WO1998054213A2 (en) * | 1997-05-30 | 1998-12-03 | Amgen Inc. | Neurotrophic factor receptors |
| US20010003580A1 (en) * | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| DE19816186A1 (de) * | 1998-04-14 | 1999-10-21 | Univ Muenchen L Maximilians | GDNF-kodierende DNA, Teile davon und GDNF-Varianten |
| FI20000394A0 (fi) * | 2000-02-21 | 2000-02-21 | Airaksinen Matti | GFRa4:n sukuisia tai siitä johdettuja aineita sekä niiden käyttö |
| CA2519227C (en) | 2003-03-19 | 2013-12-03 | Biogen Idec Ma Inc. | Nogo receptor binding protein |
| CN1897977A (zh) * | 2003-10-20 | 2007-01-17 | Ns基因公司 | 帕金森氏病的体内基因治疗 |
| US8486893B2 (en) | 2004-06-24 | 2013-07-16 | Biogen Idec Ma Inc. | Treatment of conditions involving demyelination |
| CA2583308C (en) * | 2004-10-08 | 2020-01-07 | Georgia Tech Research Corporation | Microencapsulation of cells in hydrogels using electrostatic potentials |
| HRP20131066T1 (hr) | 2005-07-08 | 2013-12-06 | Biogen Idec Ma Inc. | Sp35 antitijela i njihova upotreba |
| WO2007056161A1 (en) * | 2005-11-04 | 2007-05-18 | Biogen Idec Ma Inc. | Methods for promoting neurite outgrowth and survival of dopaminergic neurons |
| CA2729961C (en) | 2008-07-09 | 2018-05-01 | Biogen Idec Ma Inc. | Li113, li62 variant co2, anti-lingo antibodies |
| KR102142161B1 (ko) | 2012-05-14 | 2020-08-06 | 바이오젠 엠에이 인코포레이티드 | 운동 뉴런 관련 병태 치료용 lingo-2 길항제 |
| JP2018504400A (ja) | 2015-01-08 | 2018-02-15 | バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. | Lingo‐1拮抗薬及び脱髄障害の治療のための使用 |
| WO2018089702A1 (en) | 2016-11-10 | 2018-05-17 | Keros Therapeutics, Inc. | Gdnf fusion polypeptides and methods of use thereof |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| RU2690498C1 (ru) * | 2018-05-17 | 2019-06-04 | Федеральное государственное бюджетное научное учреждение "Медико-генетический научный центр" | Способ получения ноотропной композиции на основе полипептидных комплексов, выделенных из нейронов и глиальных клеток, полученных методом направленной дифференцировки индуцированных плюрипотентных стволовых клеток человека |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| RU2752906C2 (ru) * | 2019-12-26 | 2021-08-11 | Федеральное государственное бюджетное научное учреждение "Медико-генетический научный центр имени академика Н.П. Бочкова" | Ноотропная композиция на основе полипептидных комплексов, выделенных из нейрональных прогениторных клеток в условиях теплового шока, и способ ее получения |
| RU2732600C1 (ru) * | 2019-12-26 | 2020-09-21 | Федеральное государственное бюджетное научное учреждение "Медико-генетический научный центр имени академика Н.П. Бочкова" | Ноотропная композиция на основе полипептидных комплексов, выделенных из нейрональных прогениторных клеток в условиях гипоксии, и способ ее получения |
| EP4157338A4 (de) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | Verfahren zur behandlung von entzündungskrankheiten durch galectin-3-blockierung |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
| US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| US5106627A (en) | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
| US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| WO1990006952A1 (fr) | 1988-12-22 | 1990-06-28 | Kirin-Amgen, Inc. | Facteur de stimulation de colonies de granulocytes modifies chimiquement |
| JP2877509B2 (ja) | 1989-05-19 | 1999-03-31 | アムジエン・インコーポレーテツド | メタロプロテイナーゼ阻害剤 |
| AU679167B2 (en) | 1991-09-20 | 1997-06-26 | Amgen, Inc. | Glial derived neurotrophic factor |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
-
1997
- 1997-04-14 US US08/837,199 patent/US6455277B1/en not_active Expired - Lifetime
- 1997-04-15 SK SK1403-98A patent/SK140398A3/sk unknown
- 1997-04-15 JP JP9538155A patent/JP2000509271A/ja not_active Ceased
- 1997-04-15 DE DE69736597T patent/DE69736597T2/de not_active Expired - Lifetime
- 1997-04-15 AT AT97921203T patent/ATE338115T1/de not_active IP Right Cessation
- 1997-04-15 CA CA002250704A patent/CA2250704C/en not_active Expired - Fee Related
- 1997-04-15 CZ CZ983245A patent/CZ324598A3/cs unknown
- 1997-04-15 EP EP97921203A patent/EP0909316B1/de not_active Expired - Lifetime
- 1997-04-15 BR BR9708959A patent/BR9708959A/pt not_active Application Discontinuation
- 1997-04-15 AU AU27309/97A patent/AU720092B2/en not_active Ceased
- 1997-04-15 KR KR1019980708430A patent/KR20000010571A/ko not_active Abandoned
- 1997-04-15 IL IL12655397A patent/IL126553A0/xx unknown
- 1997-04-15 WO PCT/US1997/006281 patent/WO1997040152A1/en not_active Ceased
- 1997-04-15 EA EA199800933A patent/EA002924B1/ru not_active IP Right Cessation
- 1997-04-15 NZ NZ332256A patent/NZ332256A/xx unknown
- 1997-04-15 HU HU9902640A patent/HUP9902640A3/hu unknown
- 1997-04-15 ES ES97921203T patent/ES2271968T3/es not_active Expired - Lifetime
- 1997-04-15 CN CN97194013A patent/CN1219967A/zh active Pending
-
1998
- 1998-10-12 NO NO984757A patent/NO984757L/no not_active Application Discontinuation
-
2002
- 2002-05-24 US US10/155,693 patent/US20030175876A1/en not_active Abandoned
-
2006
- 2006-01-12 US US11/332,638 patent/US20060166325A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CZ324598A3 (cs) | 1999-01-13 |
| KR20000010571A (ko) | 2000-02-15 |
| DE69736597D1 (de) | 2006-10-12 |
| EP0909316B1 (de) | 2006-08-30 |
| HUP9902640A3 (en) | 2001-11-28 |
| US20060166325A1 (en) | 2006-07-27 |
| NO984757D0 (no) | 1998-10-12 |
| IL126553A0 (en) | 1999-08-17 |
| WO1997040152A1 (en) | 1997-10-30 |
| NZ332256A (en) | 2000-03-27 |
| EA199800933A1 (ru) | 1999-04-29 |
| US6455277B1 (en) | 2002-09-24 |
| EP0909316A1 (de) | 1999-04-21 |
| SK140398A3 (en) | 1999-04-13 |
| CN1219967A (zh) | 1999-06-16 |
| US20030175876A1 (en) | 2003-09-18 |
| AU720092B2 (en) | 2000-05-25 |
| ES2271968T3 (es) | 2007-04-16 |
| DE69736597T2 (de) | 2006-12-21 |
| HUP9902640A2 (hu) | 1999-11-29 |
| EA002924B1 (ru) | 2002-10-31 |
| BR9708959A (pt) | 1999-08-03 |
| NO984757L (no) | 1998-12-21 |
| CA2250704C (en) | 2005-04-12 |
| CA2250704A1 (en) | 1997-10-30 |
| JP2000509271A (ja) | 2000-07-25 |
| AU2730997A (en) | 1997-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69736597D1 (de) | Gdnf rezeptor | |
| Bennett et al. | Chemical cross-linking with thiol-cleavable reagents combined with differential mass spectrometric peptide mapping—a novel approach to assess intermolecular protein contacts | |
| WO1997033995A3 (en) | Extracellular matrix signalling molecules | |
| WO1998006048A3 (en) | Molecular modelling of neurotrophin-receptor binding | |
| WO1998054213A3 (en) | Neurotrophic factor receptors | |
| Caessens et al. | Plasmin hydrolysis of β-casein: foaming and emulsifying properties of the fractionated hydrolysate | |
| DK1179067T3 (da) | Neurobeskyttende egenskaber hos GDF-15, et medlem af TGF-beta-superfamilien | |
| ATE428785T1 (de) | Aktive und inactive cc-chemokinrezeptoren und nukleinsäuremoleküle, die für diesen rezeptor kodieren | |
| CA2471762A1 (en) | Cell-permeable peptide inhibitors of the jnk signal transduction pathway | |
| AU3143897A (en) | Oligonucleotides which specifically bind retroviral nucleocapsid proteins | |
| WO2021211631A3 (en) | Single molecule n-terminal sequencing using electrical signals | |
| AU1207301A (en) | Stabilized proteins | |
| DE69732631D1 (de) | Metabotropische gaba(b) rezeptoren, rezeptoren-spezifische liganden und deren anwendungen | |
| WO1997032020A3 (en) | Shc proteins | |
| WO2001055210A3 (en) | Human cyr61 | |
| CA2487779A1 (en) | P53 binding t cell receptor molecules and uses thereof | |
| WO1999030165A3 (en) | Processes for identifying a solvent condition suitable for determining a biophysical property of a protein | |
| Pedrotti et al. | Purified native microtubule associated protein MAP1A: kinetics of microtubule assembly and MAP1A/tubulin stoichiometry | |
| WO1998054213B1 (en) | Neurotrophic factor receptors | |
| EP0361956A3 (de) | Expression von rekombinanten Proteinen mit niedrigem Molekulargewicht | |
| WO2001087932A3 (en) | Seven transmembrane proteins and polynucleotides encoding the same | |
| Mizuno et al. | Localization of molecules involved in cytokine receptor signaling in the rat trigeminal ganglion | |
| Wang et al. | Action of peptidases in brain synaptic membranes on the NH2-terminus of adrenocorticotropin using ACTH-(1–16)-NH2 as a model substrate | |
| WO2002050273A3 (en) | A transmembrane protein as a downstream target of neurotrophin and ephrin receptor tyrosine kinases, dna encoding same monoclonal antibodies thereto | |
| Sha et al. | Receptor-Bound Conformation of α-Peptide of Transducin (Gt) is not Stabilized by a “π-Cation” Interaction but by Constrained Lactam Bridges Between Residues 341 and 350 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |